LAKE MARY, Fla. (Jan. 22)—BarrierPlus surgical gloves made by BarrierMed Inc. are undergoing review by the U.S. Food and Drug Administration with a decision on the synthetic product´s commercial use expected by April, when the firm plans a global launch of the gloves. BarrierMed, which currently manufactures neoprene examination gloves for hospitals and medical centers, also is negotiating a three-year agreement with American Health Products, a worldwide distributor of health care products, to market the surgical gloves. BarrierPlus gloves use a new cut resistant polymer technology patented by the company earlier this year, according to Victor Ragucci, BarrierMed founder and president.
BarrierMed gloves get FDA review
Rubber & Plastics News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].